Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

3(75%)

Results Posted

100%(1 trials)

Phase Distribution

Ph phase_1

75%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

3(75.0%)

Phase 2Efficacy & side effects

1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(1)

Detailed Status

Recruiting3

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 13 (75.0%)

Phase 21 (25.0%)

Trials by Status

recruiting375%

completed125%

Recent Activity

3 active trials

Showing 4 of 4

recruitingphase_1

Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1

NCT06071767

recruitingphase_2

Combination Vaccination and Broadly Neutralising Antibody Therapy in HIV

NCT07054931

recruitingphase_1

RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV

NCT06484335

completedphase_1

Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3M4 in Persons With HIV-1 Suppressed on ART

NCT05604209

Clinical Trials (4)

Showing 4 of 4 trials

NCT06071767Phase 1

Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1

Recruiting

NCT07054931Phase 2

Combination Vaccination and Broadly Neutralising Antibody Therapy in HIV

Recruiting

NCT06484335Phase 1

RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV

Recruiting

NCT05604209Phase 1

Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3M4 in Persons With HIV-1 Suppressed on ART

Completed

All 4 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 4